Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/OR/Eugene
Updated November 2026 from ClinicalTrials.gov

Paid Clinical Trials in Eugene, OR

Studies commonly pay $75 to $4,500 per completed study

148 clinical trials are currently recruiting participants within 30 miles of Eugene. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

148studies recruiting
9+research centers nearby
2condition categories
Live from the NIH registry

Studies recruiting near Eugene right now

Top 25 of 148 recruiting studies, sorted by proximity — each links to its official registry page

BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)

Limited Stage Small Cell Lung Cancer Phase 2 Interventional 250 participants sought
Oncology Associates of Oregon (Willamette Valley Cancer Institute and Research Center) — Eugene, Oregon (1.6 mi) · Sponsor: SCRI Development Innovations, LLC

Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers

Ovarian Cancer, Fallopian Tube Cancer Phase 2 Interventional 270 participants sought
517 — Eugene, Oregon (1.6 mi) · Sponsor: Corcept Therapeutics

Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma

Pancreatic Cancer, Pancreatic Cancer Metastatic Phase 3 Interventional 570 participants sought
Willamette Valley Cancer Institute — Eugene, Oregon (1.6 mi) · Sponsor: Immuneering Corporation

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

Breast Neoplasms, Neoplasm Metastasis Phase 3 Interventional 800 participants sought
Oncology Associates of Oregon — Eugene, Oregon (1.6 mi) · Sponsor: Eli Lilly and Company

A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer

High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer Phase 2 Interventional 310 participants sought
Site 0316 - Willamette Valley Cancer Institute/Oncology Associates of Oregon — Eugene, Oregon (1.6 mi) · Sponsor: K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc

Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)

Triple Negative Breast Cancer Phase 3 Interventional 1,514 participants sought
Willamette Valley Cancer Institute and Research Center — Eugene, Oregon (1.6 mi) · Sponsor: Gilead Sciences

Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL

Relapsed or Refractory Aggressive B-Cell Non-Hodgkins Lymphoma Phase 2 Interventional 130 participants sought
Oncology Associates of Oregon, P.C — Eugene, Oregon (1.6 mi) · Sponsor: Hoffmann-La Roche

A Study of Dual-task Exercise Training to Prevent Falls Among Older Adults With Mild Cognitive Impairment

Mild Cognitive Impairment, Accidental Falls N/A Interventional 336 participants sought
Oregon Research Institute — Springfield, Oregon (4.8 mi) · Sponsor: Oregon Research Institute

Safety and Effectiveness of the PXL-Platinum 330 System for Corneal Cross-Linking

Keratoconus, Unstable, Bacterial Keratitis Phase 1 Interventional 300 participants sought
Pacific Clear Vision Institute — Eugene, Oregon (1.6 mi) · Sponsor: Pacific Clear Vision Institute

A Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants Receiving Oral Venetoclax in Combination With Intravenously Infused Obinutuzumab or Oral Acalabrutinib for Previously Untreated Chronic Lymphocytic Leukemia (CLL)

Chronic Lymphocytic Leukemia Phase 3 Interventional 170 participants sought
Willamette Valley Cancer Institute and Research Center /ID# 266326 — Eugene, Oregon (1.6 mi) · Sponsor: AbbVie

A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)

Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Phase 2, Phase 3 Interventional 690 participants sought
Oncology Associates Of Oregon, Pc — Eugene, Oregon (1.6 mi) · Sponsor: Bristol-Myers Squibb

Testing Just-in-Time Adaptive Interventions (JITAIs) to Prevent Goal Disengagement in Response to Weight Regain

Overweight or Obesity N/A Interventional 120 participants sought
Oregon Research Institute Community and Evaluation Services — Springfield, Oregon (4.8 mi) · Sponsor: ORI Community and Evaluation Services

A Clinical Study of MK-4208/TERN-701 in Participants With Chronic Myeloid Leukemia (CML) (MK-4208-003/Tern701-1012/CARDINAL)

Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Chronic Myeloid Leukemia, Chronic Phase Phase 1, Phase 2 Interventional 330 participants sought
Willamette Valley Cancer Institute and Research Center — Eugene, Oregon (1.6 mi) · Sponsor: Terns, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

Intracept Minimally-invasive PROcedure for VErtebrogenic Back Pain

Chronic Low-back Pain, Vertebrogenic Pain Syndrome N/A Observational 1,500 participants sought
Pacific Sports and Spine — Eugene, Oregon (1.6 mi) · Sponsor: Boston Scientific Corporation

A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

Non-small Cell Carcinoma, Non-Small Cell Lung Cancer Metastatic Phase 3 Interventional 680 participants sought
Oncology Associates of Oregon, P.C. — Eugene, Oregon (1.6 mi) · Sponsor: Pfizer

A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy

Geographic Atrophy, Macular Degeneration N/A Observational 500 participants sought
Verum Research, LLC — Eugene, Oregon (1.6 mi) · Sponsor: Astellas Pharma Global Development, Inc.

Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis

Generalized Myasthenia Gravis Phase 3 Interventional 231 participants sought
Site Number - 1031 — Eugene, Oregon (1.6 mi) · Sponsor: Immunovant Sciences GmbH

A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia

Chronic Lymphocytic Leukemia Phase 3 Interventional 500 participants sought
Oncology Associates of Oregon Willamette Valley Cancer Center — Eugene, Oregon (1.6 mi) · Sponsor: BeOne Medicines

A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)

Non-small Cell Lung Cancer (NSCLC) Phase 3 Interventional 850 participants sought
Oncology Associates Of Oregon, Pc — Eugene, Oregon (1.6 mi) · Sponsor: Bristol-Myers Squibb

Data2Action Oregon Project: Supporting Data-driven Decision-Making for Substance Use Services, Policy, and Overdose Prevention

Substance Abuse, Decision Making, Shared N/A Interventional 341 participants sought
Chestnut Health Systems — Eugene, Oregon (1.6 mi) · Sponsor: Chestnut Health Systems

A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.

Epithelial Ovarian Cancer, Fallopian Tube Cancer Phase 2 Interventional 140 participants sought
Oncology Associates of Oregon, P.C. /ID# 275006 — Eugene, Oregon (1.6 mi) · Sponsor: AbbVie

A Study of Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants With Metastatic Colorectal Cancer (FRUITFUL)

Colon Cancer, Rectal Cancer Phase 2 Interventional 60 participants sought
Oncology Associates of Oregon - Primary — Eugene, Oregon (1.6 mi) · Sponsor: SCRI Development Innovations, LLC
Actively enrolling

Studies you may be able to join near Eugene

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

See which clinical studies you may qualify for

A partner research network matches volunteers with studies that are currently enrolling in the United States. You answer a few screening questions about your health and where you live; if a study looks like a fit, its team contacts you to confirm eligibility.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Google-rated

Top-rated research centers in Eugene

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Willamette Valley Cancer Institute and Research Center - Eugene

★ 4.2 (87 reviews)
520 Country Club Rd, Eugene, OR 97401
(541) 683-5001
"Dr's & nurses are great but they seem super disorganized! They keep changing my son's infusion times. Nobody has called about getting his port. Monda…"
— Jennifer Hernandez, 2★

University of Oregon Prevention Science Institute

University of Oregon, 1600 Millrace Dr, Eugene, OR 97403
(541) 346-3630

The Alliance for Community Wellness

★ 4.6
1195 City View St, Eugene, OR 97402
(541) 342-5394
"They came across to me like people who really care about other people.They listen to me and they've offered me help.I feel very blessed to have found…"
— Jared Watts, 5★

Robert and Beverly Lewis Integrative Science Building

★ 5.0
University of Oregon, Eugene, OR 97401

Benson Health Clinic

★ 3.2 (40 reviews)
66 Club Rd Ste 140, Eugene, OR 97401
(541) 345-1722
"I've worked with Dr. Lumos for a few years and have had great support in sessions! Kind, empathetic, and flexible. Solid front desk staff, though I'v…"
— Jade, 4★

OHSU Child Development and Rehabilitation Center, Eugene

★ 3.1
74 B Centennial Loop STE 100, Eugene, OR 97401
(503) 346-1640
"Been on a supposed waitlist for well over a year to get my son seen. They told my son’s doctor they called several times and I never answered. Though…"
— Mary Bates, 1★

Oregon Social Learning Center

★ 4.4
10 Shelton Mcmurphey Blvd, Eugene, OR 97401
(541) 485-2711

Willamette Valley Cancer Institute and Research Center - Springfield

★ 3.3 (3 reviews)
3355 Riverbend Dr #240, Springfield, OR 97477
(541) 683-5001
"The organization is lacking and has made me feel uncared for due to what seems to be a lack of accountability. Although I've received apologies, ther…"
— C M, 1★

Lewis Integrative Science Building

1440 Franklin Blvd, Eugene, OR 97403

Clinical trials in Eugene: what's recruiting

The Eugene area currently has 148 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Eugene, the most active research areas are:

  • Cancer & Oncology14 studies
  • Diabetes & Metabolism1 studies

Every listing shows the study phase, the recruiting site and its distance from Eugene, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Eugene

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Eugene participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

Do I need to be sick to join a clinical trial in Eugene?
No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.
Are clinical trials in Eugene safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
What is the difference between a research center and a hospital study in Eugene?
Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.
How often do new paid studies open in Eugene?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Eugene.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Eugene typically complete one or two studies per year.

Paid clinical trials near Eugene

Other metros within reach

By condition

Eligibility and exclusions, condition by condition

More of OR

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

Get free trial alerts